Cresilon

New York, NY · Founded 2012 · Privately Held (backing)

Developer of hemostatic products designed to support the natural clotting and promote wound healing. Cresilon is based in New York, NY and was founded in 2012. Its last reported valuation was $340 million in Apr 2024. It has raised $160 million across 8 recorded rounds; the latest was a $29 million early-stage round in Apr 2026.

Last reported valuation
$340.0M
Oct 2026
Priced at
—
Total raised
$159.5M
Last round
Early Stage VC
Apr 2026
What is Cresilon worth?
$340.0Mlast reported valuation · Oct 2026

Cresilon's last reported valuation, Apr 2024. Nothing priced has surfaced since.

Free account
More of Cresilon with a free account
  • ·The complete investor list: 20 names
  • ·Watch Cresilon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Cresilon funding history

8 rounds
DateRoundRaisedPost-money
Apr 2026Early Stage VC$29.0M▮
Nov 2025Early Stage VC$6.7M▮
Apr 2025Early Stage VC$17.2M▮
Apr 2024Early Stage VC$25.0M▮
Aug 2023Early Stage VC$17.2M▮
Dec 2021Early Stage VC$25.0M▮
+ 2 earlier rounds · a free account shows the full history
Unlock post-money valuations

Membership and data by Private Market View

Cresilon valuation

Cresilon's last reported valuation was $340 million in Apr 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Cresilon raised?

Cresilon has raised $160 million across 8 recorded rounds since 2017. The largest was a $6.7 million early-stage round in Nov 2025; the most recent was a $29 million early-stage round in Apr 2026.

Cresilon has filed 8 Form Ds with the SEC since 2018, most recently in Jun 2026 ($29 million sold to 217 investors).

How Cresilon's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Cresilon, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Cresilon

What is Cresilon worth?
Cresilon is valued at $340.0M as of Oct 2026. Cresilon's last reported valuation, Apr 2024. Nothing priced has surfaced since.
How much has Cresilon raised?
Cresilon has raised $159.5M in total funding across 8 recorded rounds.
When did Cresilon last raise?
Cresilon last raised in Apr 2026 (Early Stage VC), raising $29.0M.